VAISHALI PHARMA
Back to Balance Sheet
|
VAISHALI PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-0.18 Cr | ₹-0.14 Cr | ₹-0.16 Cr | ₹-0.15 Cr | ₹-0.12 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of VAISHALI PHARMA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-0.18 Cr |
Mar2023 | ₹-0.14 Cr |
Mar2022 | ₹-0.16 Cr |
Mar2021 | ₹-0.15 Cr |
Mar2020 | ₹-0.12 Cr |
How is Deferred Tax Assets / Liabilities of VAISHALI PHARMA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-0.18 Cr | Negative | |
Mar2023 | ₹-0.14 Cr | Negative | |
Mar2022 | ₹-0.16 Cr | Negative | |
Mar2021 | ₹-0.15 Cr | Negative | |
Mar2020 | ₹-0.12 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of VAISHALI PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VAISHALI PHARMA | ₹162.3 Cr | 3.2% | -0.4% | -25% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,971.0 Cr | -4.6% | 0.7% | 10.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,153.0 Cr | -1.2% | 12.6% | 51.2% | Stock Analytics | |
CIPLA | ₹122,717.0 Cr | 0.7% | 6% | 9.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,392.0 Cr | -1.8% | -0.4% | 25.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,702.0 Cr | 4% | 8.9% | -1.3% | Stock Analytics |
VAISHALI PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VAISHALI PHARMA | 3.2% |
-0.4% |
-25% |
SENSEX | 0.6% |
11% |
10.4% |
You may also like the below Video Courses